Global Health
Modelling study: 100 Days Mission demands vaccine equity
A study in The Lancet Global Health estimates the impact that the 100 Days Mission could have had on the COVID-19 pandemic. The authors
Study: TCV protects children against typhoid but declines
A study in The Lancet in October 2024 finds that a single dose of typhoid conjugate vaccine (TCV) offers safe and effective protection against typhoid two
AMR report: vaccines could reduce antibiotics needed by 22%
A WHO report in October 2024 suggests that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% every year.
WHO, IMF, and WBG agree on pandemic preparedness principles
In October 2024, WHO announced an agreement with the International Monetary Fund (IMF) and the World Bank Group (WBG) on “broad principles
Wellcome funding to overcome AMA capacity challenges
The African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD) announced in October 2024 that Wellcome
Japan and DRC agree on Lc16 mpox vaccine donations
In September 2024, Africa CDC offered congratulations to the Governments of Japan and the Democratic Republic of the Congo (DRC) for their agreement on the donation of Lc16 mpox vaccines and specialised inoculation needles. At a signing ceremony in Kinshasa, the two...
Global Fund to support DRC with $9.5 million against mpox
The Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund) announced in September 2024 that it is responding to a request from the government of the Democratic Republic of the Congo (DRC) for support in its mpox response. The Global Fund will provide...
Gavi funds APA for 500,000 MVA-BN doses for Africa
In September 2024, Gavi and Bavarian Nordic announced an advance purchase agreement (APA) to secure 500,000 doses of MVA-BN mpox vaccine to be supplied to countries in Africa that are affected by the mpox outbreak. The doses are funded by Gavi’s First Response Fund...
NHS urges childhood vaccination as data show low coverage
A statistical report from UKHSA and NHS England in September 2024 reveals a drop in childhood vaccination coverage in England in 2023-2024. The report uses data from the COVER (cover of vaccination evaluated rapidly) programme, which collates information for children...
Polio campaign in Gaza reaches around 560,000 children
The first round of an emergency polio vaccination campaign in the Gaza Strip reached around 560,000 children under ten between 1st and 12th September 2024. WHO reported that the campaign delivered novel oral polio vaccine type 2 (nOPV2) to 558,963 children after the...
WHO and partners launch AAM for mpox countermeasures
In September 2024 WHO announced the establishment of an access and allocation mechanism for mpox medical countermeasures, including vaccines, treatments, and diagnostic tests. The Access and Allocation Mechanism (AAM) is intended to increase access to these essential...
HPV vaccines: Angola arms itself against cervical cancer
WHO Africa announced in September 2024 that more than 1,400,000 doses of human papillomavirus (HPV) vaccine have arrived in Angola as part of the national strategy for prevention and protection against cervical cancer. HPV is recognised as the “leading cause of more...
Study: need for clinical surveillance of patients with C-VAM
An FDA-funded study in eClinical Medicine explores the clinical characteristics, myocardial injury, and longitudinal outcomes of COVID-19 vaccine-associated myocarditis (C-VAM). The authors provide a “detailed phenotypic clinical characterisation” of C-VAM in 33...
15,460 additional mpox vaccine doses arrive in DRC
Gavi announced in September 2024 that a shipment of 15,460 doses of mpox vaccine has arrived in the Democratic Republic of the Congo (DRC) to “support the global and regional effort to contain the outbreak”. These doses were donated by manufacturer Bavarian Nordic to...
Cancer Research UK funds Oxford’s ‘LynchVax’ efforts
The University of Oxford’s Centre for Cancer Early Detection and Prevention announced in September 2024 that Cancer Research UK has awarded a team of scientists up to £550,000 to carry out “underpinning work” to test a vaccine for patients with Lynch syndrome. Lynch...
Study: cost-effectiveness of RSV vaccination in Canada
A study in CMAJ in September 2024 evaluates the cost-effectiveness of different age cut-offs for RSV adult vaccination programmes, with or without a focus on people with higher disease risk. The authors compared alternative age-, medical risk-, and age- and medical...
Use of suppressive bluetongue vaccines permitted in UK
The UK Department for Environment, Food, and Rural Affairs (DEFRA) announced in September 2024 that the Secretary of State has permitted the use of three unauthorised bluetongue serotype 3 (BTV-3) vaccines in the United Kingdom. The vaccines can be used with an...
Partnership to protect pigs awarded government funding
The Vaccine Group (TVG) announced in September 2024 that its partnership with the University of Plymouth and the University of Cambridge has been awarded “significant” government funding to develop a vaccine to stop the development and spread of Streptococcus suis....
Phase 1 of Gaza polio vaccination conducted “successfully”
WHO announced in September 2024 that the first phase of a polio vaccination campaign has been “successfully” completed in Gaza. Over 187,000 children under ten years were vaccinated with novel oral polio vaccine type 2 (nOPV2) in central Gaza between 1st and 3rd...
First mpox vaccine doses arrive in DRC from Bavarian Nordic
Bavarian Nordic announced in September 2024 that the first doses of its mpox vaccine, MVA-BN (JYNNEOS), have arrived in the Democratic Republic of Congo (DRC) to support response efforts. Further shipments are planned within the next few days, contributing to a total...
